Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Thu, 25 May 17 02:52:35 +0000 Thu, 25 May 17 02:52:35 +0000 Equashield to Open New $30 Million Manufacturing Facility to Accommodate Future Growth in Product Portfolio and Increase Production Capabilities http://www.pharmacytimes.com/news/equashield-to-open-new-30-million-manufacturing-facility-to-accommodate-future-growth-in-product-portfolio-and-increase-production-capabilities http://www.pharmacytimes.com/news/equashield-to-open-new-30-million-manufacturing-facility-to-accommodate-future-growth-in-product-portfolio-and-increase-production-capabilities Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. Wed, 24 May 17 00:00:00 +0000 Smart Trap Increasingly Accurate in Catching Zika, West Nile Mosquitoes http://www.pharmacytimes.com/news/smart-trap-increasingly-accurate-in-catching-zika-west-nile-mosquitoes http://www.pharmacytimes.com/news/smart-trap-increasingly-accurate-in-catching-zika-west-nile-mosquitoes Houston Public Media today reported on a &ldquo;smart trap&rdquo; by Microsoft&nbsp;that Harris County Mosquito Control has been testing since summer 2016. Tue, 23 May 17 12:00:00 +0000 Rheumatoid Arthritis Drug Wins FDA Approval http://www.pharmacytimes.com/product-news/rheumatoid-arthritis-drug-wins-fda-approval http://www.pharmacytimes.com/product-news/rheumatoid-arthritis-drug-wins-fda-approval The FDA has approved sarilumab (Kevzara) from Sanofi and Regeneron Pharmaceuticals for the treatment of adult patients with moderately to severely active rheumatoid arthritis. Tue, 23 May 17 00:00:00 +0000 Could This Cancer Drug Benefit Patients with Severe Asthma? http://www.pharmacytimes.com/news/could-this-cancer-drug-benefit-patients-with-severe-asthma http://www.pharmacytimes.com/news/could-this-cancer-drug-benefit-patients-with-severe-asthma An early-phase study suggests that a targeted cancer drug, imatinib (Gleevec, Novartis), may help treat patients with severe asthma. Fri, 19 May 17 10:08:55 +0000 Kalydeco Now Approved for Expanded Cystic Fibrosis Treatment http://www.pharmacytimes.com/product-news/kalydeco-now-approved-for-expanded-cystic-fibrosis-treatment http://www.pharmacytimes.com/product-news/kalydeco-now-approved-for-expanded-cystic-fibrosis-treatment FDA officials have announced the expanded approval of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to triple the number of rare gene mutations of cystic fibrosis that the drug is indicated to treat, from 10 mutations to 33.&nbsp;<br /> &nbsp; Thu, 18 May 17 15:12:19 +0000 FDA Issues Safety Alert for Canagliflozin http://www.pharmacytimes.com/news/fda-issues-safety-alert-for-canagliflozin http://www.pharmacytimes.com/news/fda-issues-safety-alert-for-canagliflozin The new warning is based on recent data from 2 clinical trials. Tue, 16 May 17 21:03:51 +0000 Urine Test Identifies Zika Virus Fast, Could Prevent Birth Defects http://www.pharmacytimes.com/news/urine-test-identifies-zika-virus-fast-could-prevent-birth-defects http://www.pharmacytimes.com/news/urine-test-identifies-zika-virus-fast-could-prevent-birth-defects The results of a recent study from Beaumont Hospital in Royal Oak, Michigan, show that Zika virus can be identified by a urine test that does not require administration by a doctor and that delivers results in less than 30 minutes. Tue, 16 May 17 18:49:25 +0000 CDC Report Focuses on Slowing Hepatitis C Infection Rate http://www.pharmacytimes.com/news/cdc-report-focuses-on-slowing-hepatitis-c-infection-rate http://www.pharmacytimes.com/news/cdc-report-focuses-on-slowing-hepatitis-c-infection-rate Hepatitis C virus infection rates are the highest in 15 years, according to recent data released by the CDC. Tue, 16 May 17 13:30:24 +0000 6 New FDA Approvals to Know from April 2017 http://www.pharmacytimes.com/news/6-new-fda-approvals-to-know-from-april-2017 http://www.pharmacytimes.com/news/6-new-fda-approvals-to-know-from-april-2017 Learn about the new products and expanded indications approved by the FDA in April 2017. Sun, 14 May 17 20:55:21 +0000 Pharmacy Society of Wisconsin Teams with Attorney General to Reduce Pharmacy Armed Robbery http://www.pharmacytimes.com/news/pharmacy-society-of-wisconsin-teams-with-attorney-general-to-reduce-pharmacy-armed-robbery http://www.pharmacytimes.com/news/pharmacy-society-of-wisconsin-teams-with-attorney-general-to-reduce-pharmacy-armed-robbery For all these reasons and our own personal safety and that of our staff, we have a duty as pharmacists to &ldquo;limit the violence&rdquo; in our workplace.<br /> &nbsp; Fri, 12 May 17 14:34:15 +0000 Could Beer Be the Answer to Future Novel Pain Therapies? http://www.pharmacytimes.com/news/could-beer-be-the-answer-to-future-novel-pain-therapies http://www.pharmacytimes.com/news/could-beer-be-the-answer-to-future-novel-pain-therapies Having a few alcoholic beverages may be just as effective as some pain medications from the pharmacy, according to research from a new study.&nbsp; Fri, 12 May 17 14:17:45 +0000 3 Words Nobody Should Say in the Pharmacy http://www.pharmacytimes.com/news/3-words-nobody-should-say-in-the-pharmacy http://www.pharmacytimes.com/news/3-words-nobody-should-say-in-the-pharmacy Each day you encounter patients with multiple and various disease states, alignments, and questions. For some, questions they initially didn&rsquo;t think they even had. Fri, 12 May 17 11:19:08 +0000 Drug Safety Concerns Often Noted After Receiving FDA Approval http://www.pharmacytimes.com/news/drug-safety-concerns-often-noted-after-receiving-fda-approval- http://www.pharmacytimes.com/news/drug-safety-concerns-often-noted-after-receiving-fda-approval- Overall, postmarket safety events were significantly more frequent among biologics, psychiatric therapeutics, drugs that received accelerated approval, and those with near-regulatory deadline approval. &nbsp; Fri, 12 May 17 09:53:23 +0000 FDA Officials Update Fluoroquinolone Warning http://www.pharmacytimes.com/news/fda-officials-update-fluoroquinolone-warning http://www.pharmacytimes.com/news/fda-officials-update-fluoroquinolone-warning As part of an ongoing review of fluoroquinolone antibiotics, FDA is informing the public that patient cases identified by the FDA and findings from published studies currently do not support reports that these medicines may result in detachment of the retina in the eyes, or bulges or tears in the aorta blood vessel. Thu, 11 May 17 15:18:25 +0000 Physician Receives 10-Year Sentence for Pill Mill Operation http://www.pharmacytimes.com/news/physician-receives-10year-sentence-for-pill-mill-operation http://www.pharmacytimes.com/news/physician-receives-10year-sentence-for-pill-mill-operation A physician was sentenced this week for operating a drug distribution scheme out of his medical practice and for money laundering, according to a DEA press release.&nbsp; Thu, 11 May 17 13:52:59 +0000 FDA Approves Bavencio for Advanced Bladder Cancer http://www.pharmacytimes.com/product-news/fda-approves-bavencio-for-advanced-bladder-cancer http://www.pharmacytimes.com/product-news/fda-approves-bavencio-for-advanced-bladder-cancer The FDA has granted approval to avelumab (Bavencio, Pfizer) injection for treatment of patients with locally advanced or metastatic urothelial carcinoma (UC).&nbsp; Wed, 10 May 17 00:34:29 +0000 Scott Gottlieb Confirmed as FDA Lead http://www.pharmacytimes.com/news/scott-gottlieb-confirmed-as-fda-lead http://www.pharmacytimes.com/news/scott-gottlieb-confirmed-as-fda-lead The Senate has confirmed President Donald Trump&#39;s pick, Scott Gottlieb, MD,&nbsp;to head the FDA, according to several published media reports.<br /> &nbsp; Tue, 09 May 17 22:09:20 +0000 Life Expectancy Trends Reveal Growing Geographic Disparities http://www.pharmacytimes.com/news/life-expectancy-trends-reveal-growing-geographic-disparities http://www.pharmacytimes.com/news/life-expectancy-trends-reveal-growing-geographic-disparities The Institute for Health Metrics and Evaluation (IHME) offered insight into lifespan trends throughout the United States over the past several decades.&nbsp; Tue, 09 May 17 16:09:32 +0000 Buprenorphine or Morphine for Treatment of Neonatal Abstinence Syndrome? http://www.pharmacytimes.com/news/buprenorphine-or-morphine-for-treatment-of-neonatal-abstinence-syndrome http://www.pharmacytimes.com/news/buprenorphine-or-morphine-for-treatment-of-neonatal-abstinence-syndrome Buprenorphine could potentially have better treatment outcomes in infants with neonatal abstinence syndrome (NAS) than traditionally used oral morphine, according to a study recently published in the <em>New England Journal of Medicine</em>.&nbsp;<br /> &nbsp; Tue, 09 May 17 15:30:39 +0000 Kisqali Femara Co-Packaging Approved for Breast Cancer Treatment http://www.pharmacytimes.com/news/kisqali-femara-copackaging-approved-for-breast-cancer-treatment http://www.pharmacytimes.com/news/kisqali-femara-copackaging-approved-for-breast-cancer-treatment The Kisqali Femara Co-Pack is the only approved combination pack that includes 2 prescription drugs used to treat breast cancer. Tue, 09 May 17 14:09:19 +0000 Dietary Supplement Recall Issued Due to Anabolic Steroids http://www.pharmacytimes.com/news/dietary-supplement-recall-issued-due-to-anabolic-steroids http://www.pharmacytimes.com/news/dietary-supplement-recall-issued-due-to-anabolic-steroids The product is packaged&nbsp;with UPC code 0058049984 and can be identified by GEC Laxoplex. Mon, 08 May 17 19:34:52 +0000 OTC Cough and Cold Medication Related Adverse Events in Children http://www.pharmacytimes.com/news/otc-cough-and-cold-medication-related-adverse-events-in-children http://www.pharmacytimes.com/news/otc-cough-and-cold-medication-related-adverse-events-in-children Many adverse events associated with OTC cold medications are related to accidental unsupervised ingestions or dosing errors, which means better education from pharmacists and other health care providers may help reduce these events, according to a study published in <em>Pediatrics</em> this month.<br /> &nbsp; Mon, 08 May 17 13:56:19 +0000 FDA Approves ALS Treatment http://www.pharmacytimes.com/product-news/fda-approves-als-treatment http://www.pharmacytimes.com/product-news/fda-approves-als-treatment The FDA has approved edaravone (Radicava, Mitsubishi Tanabe Pharma America) for the treatment of amyotrophic lateral sclerosis (ALS), the first new ALS therapy approved by the FDA in several years.&nbsp;<br /> &nbsp; Sat, 06 May 17 13:53:10 +0000 Does Low-Dose Aspirin Reduce Risk of Breast Cancer? http://www.pharmacytimes.com/news/does-lowdose-aspirin-reduce-risk-of-breast-cancer http://www.pharmacytimes.com/news/does-lowdose-aspirin-reduce-risk-of-breast-cancer Low-dose aspirin may help women reduce their risk of developing breast cancer, a new study published in <em>Breast Cancer Research</em> has suggested. Fri, 05 May 17 14:26:25 +0000 House Passes Revised American Health Care Act http://www.pharmacytimes.com/news/house-passes-revised-american-health-care-act http://www.pharmacytimes.com/news/house-passes-revised-american-health-care-act The Republican-drafted health care legislation known as the American Health Care Act (AHCA) narrowly passed in the House on Thursday in a 217-213 vote.&nbsp; Thu, 04 May 17 21:09:10 +0000